DSM Sinochem Pharmaceuticals

About DSM Sinochem Pharmaceuticals

Centrient Pharmaceuticals (until December 2018 known as DSM Sinochem Pharmaceuticals) is the global leader in sustainable antibiotics, next-generation statins and anti-fungals. Centrient develops, produces and sells intermediates, active pharmaceutical ingredients and drug products. Our employees worldwide work together to deliver cutting-edge generics solutions that help to keep customers ahead of the competition.

Headquartered in Rotterdam, Netherlands, the group has manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital, a leading global investment firm.

Keywords

• Drug Products With Pureactives Api
• Enzymatically Produced Beta-Lactam Antibiotics
• Enzymatically Produced Generic Apis
• Enzymatically Produced Statins
• Sustainable Antibiotics

Address

• Headquarters

  800 Weena3014DA RotterdamZuid-Holland, Netherlands

Team by function

Based on 58 public job profiles as of 4 August 2026.

• Operations13
• Other / Unclassifiable8
• Administrative / Office7
• Finance / Accounting5
• Manufacturing / Production5
• Marketing4
• Sales4
• Engineering / Software Development3
• Customer Success / Support2
• Skilled Trades / Technical2
• Design / UX1
• Executive / C-Suite1
• HR / People / Recruiting1
• IT / Infrastructure / Security1
• Research / R&D1